Validatie van Nanobody en antilichamen gebaseerde<em> In Vivo</em> Tumor Xenograft NIRF-imaging Experimenten op muizen, waarbij<em> Ex Vivo</em> Flowcytometrie en Microscopie
Validatie van Nanobody en antilichamen gebaseerde<em> In Vivo</em> Tumor Xenograft NIRF-imaging Experimenten op muizen, waarbij<em> Ex Vivo</em> Flowcytometrie en Microscopie
This protocol outlines the steps required to perform ex vivo validation of in vivo near-infrared fluorescence xenograft imaging experiments in mice using fluorophore labelled nanobodies and conventional antibodies.
Bannas, P., Lenz, A., Kunick, V., Fumey, W., Rissiek, B., Schmid, J., Haag, F., Leingärtner, A., Trepel, M., Adam, G., Koch-Nolte, F. Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy. J. Vis. Exp. (98), e52462, doi:10.3791/52462 (2015).